Interleukin-35 Suppresses Interleukin-9-Secreting CD4+ T Cell Activity in Patients With Hepatitis B-Related Hepatocellular Carcinoma

Chronic hepatitis B virus (HBV) infection induces dysfunction of immune response and chronic liver damage. However, the mechanisms that account for HBV-related hepatocellular carcinoma (HCC) are poorly understood. The aim of present study was to investigate the modulatory role of interleukin (IL)-35...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Qian Zhang, Lanlan Yang, Siqi Liu, Mengyao Zhang, Zhenjing Jin
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2021-06-01
coleção:	Frontiers in Immunology
Assuntos:	interleukin-35 interleukin-9 T cells hepatitis B virus hepatocellular carcinoma
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.645835/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!